Project Grant S10GM164840
Award Date 7/1/26
Completion Date 3/31/27
Dollars Obligated $176K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
- Federal Grant Award Summary Eastern Washington University received a $248,580 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2026. The award funds the acquisition and installation of a Leica Microsystems Thunder Imager Live Cell, an automated brightfield, phase contrast, and inverted fluorescence microscope system equipped with an on-stage...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $427,625 Project Grant to the University of Washington, effective September 1, 2025, through August 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of capillaric microfluidics technology for integrated, self-powered, and self-regulated sample preparation in miniaturized mass spectrometry (MS) systems. The research addresses a...
- Federal Grant Award Summary East Tennessee State University received a $250,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 1, 2026, with completion targeted by May 31, 2027. The award funds the acquisition and installation of a Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) system to serve the university's Academic Health Science Center. This instrument...
- Federal Grant Award Summary The University of Washington received a $1.37M Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to develop analytical tools for monitoring proline isomerization in proteins. Awarded June 1, 2026, with a completion date of May 31, 2030, this research initiative will advance structural proteomics by creating a tandem proteolysis methodology that integrates cold...
- Federal Project Grant Award Summary The University of Washington received a $388,750 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through April 30, 2031. The award funds mechanistic research to advance translational science in drug pharmacokinetics and interindividual variability in adverse drug reactions. The research employs mechanistic in vitro studies, mass...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Washington State University $406,037 on April 5, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support advanced analytical chemistry research led by the Clowers Research Group. The project, titled "Capturing Isomeric Heterogeneity and Structural Dynamics Using Transformative Ion Manipulation Platforms," will run through February 28, 2031, and...
- Federal Grant Award Summary St. John's University received a $249,574 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) effective July 1, 2026, through June 30, 2027. The award funds the acquisition and installation of a Shimadzu LCMS-8045RX triple quadrupole liquid chromatography-tandem mass spectrometry (LC-MS/MS) system with Nexera XS ultra-high performance liquid chromatography (UHPLC)...
- Federal Project Grant Award Summary The University of Washington received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. This award funds fundamental research investigating the molecular coordination between two critical second messenger signaling pathways—cyclic diguanylate monophosphate (c-di-GMP) and cyclic adenosine...
- Federal Project Grant Summary Eastern Washington University received a $470,978 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 9, 2026, with completion expected March 31, 2029. The award funds basic biochemical research to characterize DAHP (3-deoxy-D-arabino-heptulosonate 7-phosphate) synthases in Pseudomonas aeruginosa, a highly antimicrobial-resistant...
- Federal Grant Award Summary Western Michigan University received a $558,493 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 11, 2025, with a completion date of August 31, 2028. The award supports fundamental research to elucidate the chemical and catalytic mechanisms of hypothiocyanous acid reductase (HAR), an enzyme expressed by human-colonizing bacteria including major...